Gene Synthesis Market Size, Share, Growth, Trends, and Forecast 2026-2035 | 21.20% CAGR Fueled by Synthetic Biology, Gene Therapy, and Custom DNA Demand
Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -- "Gene Synthesis Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035)" has been added to ResearchAndMarkets.com's offering.
The global gene synthesis market reached USD 2.93 Billion in 2025 and is projected to grow at a CAGR of 21.20% from 2026-2035, attaining USD 20.04 Billion by 2035. Market expansion is supported by increasing investment in synthetic biology, gene therapy pipelines and biopharmaceutical R&D, alongside rising demand for custom gene synthesis services and codon optimization. Broader use of genomics-driven therapy, biomarker-based treatment, molecular profiling and advanced genome editing is also strengthening the outlook for high-precision DNA synthesis services.
Key Gene Synthesis Market Insights
Technology Innovation Supports Market Growth
Advances in secure, automated gene synthesis are improving data protection, operational efficiency and intellectual property security. These capabilities are becoming increasingly important as biotechnology companies manage sensitive DNA sequences and more complex development programs. In April 2026, Beijing Tsingke Biotech Co., Ltd. introduced its "Zero-Contact Sequences" system for fully automated, on-site gene synthesis with minimal human intervention. The system reflects growing industry demand for secure workflows that reduce exposure risks while supporting faster research and development.
Progress in ultra-long DNA synthesis represents another important gene synthesis market trend. The ability to produce longer, sequence-perfect DNA constructs with full verification can shorten turnaround times and support more sophisticated therapeutic and research applications. In October 2025, Ansa Biotechnologies introduced a 50 kb clonal DNA product offering rapid delivery and complete sequence verification. Developments of this kind are expected to advance genomics-driven therapy, drug response prediction, molecular profiling and precision research.
Gene Synthesis Market Segmentation
The market is analyzed by components, gene therapy, application, gene synthesis type and region.
Solid-Phase Synthesis Maintains a Strong Market Position
Solid-phase synthesis is expected to remain a prominent gene synthesis type due to its accuracy, scalability and efficiency in producing custom DNA sequences. Demand is being reinforced by applications in gene cloning, patient stratification, AI diagnostics, biomarker development and drug response prediction. Continued investment in CRISPR-based genome editing and commercial-scale DNA manufacturing is likely to support adoption across pharmaceutical, biotechnology and academic research organizations.
Regional Gene Synthesis Market Outlook
North America is expected to lead the global market, supported by its established biotechnology ecosystem, advanced research infrastructure, strong funding environment and concentration of major industry participants. Europe also represents an important market, benefiting from pharmaceutical research and established sequencing capabilities. Asia Pacific is forecast to achieve the fastest growth as governments increase investment in biopharmaceutical manufacturing and synthetic biology research, particularly in China and India. Latin America and the Middle East and Africa are expected to present longer-term opportunities as genomics infrastructure and access to advanced research services improve.
Competitive Landscape
The gene synthesis market includes specialized DNA providers, synthetic biology companies and diversified life sciences organizations. Competitive strategies center on faster delivery, longer DNA constructs, improved sequence accuracy, manufacturing scale, partnerships and acquisitions.
Other notable participants include General Biosystems, Macrogen Co., Ltd., Boster Biological Technology, Creative Biogene, Exonbio, Bioneer Corporation, Trenzyme GmbH, BioCat GmbH, OriGene Technologies, Inc., NZYTech, and Genes and Enzymes.
Report Scope
The gene synthesis market report evaluates historical performance and the forecast outlook for 2026-2035. It examines market drivers, opportunities, restraints, unmet needs and technology trends across major segments and regions. The analysis also covers patents, funding, investment activity and strategic initiatives, including partnerships, collaborations, mergers and acquisitions that are shaping competition and future market development.
Key Topics Covered
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Gene Synthesis Market Overview
3.1 Global Gene Synthesis Market Historical Value (2019-2025)
3.2 Global Gene Synthesis Market Forecast Value (2026-2035)
4 Global Gene Synthesis Market Landscape
4.1 Gene Synthesis: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Gene Synthesis: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Gene Synthesis Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Gene Synthesis Market Segmentation
6.1 Global Gene Synthesis Market by Components
6.1.1 Market Overview
6.1.2 Synthesizer
6.1.3 Consumables
6.1.4 Software and Services
6.2 Global Gene Synthesis Market by Gene Therapy
6.2.1 Market Overview
6.2.2 Standard Gene
6.2.3 Express Gene
6.2.4 Complex Gene
6.2.5 Others
6.3 Global Gene Synthesis Market by Application
6.3.1 Market Overview
6.3.2 Synthetic Biology
6.3.3 Genetic Engineering
6.3.4 Vaccine Design
6.3.5 Therapeutics Antibodies
6.3.6 Others
6.4 Global Gene Synthesis Market by Gene Synthesis Type
6.4.1 Market Overview
6.4.2 Gene Library Synthesis
6.4.3 Solid Phase Synthesis
6.4.4 Chip-Based DNA Synthesis
6.4.5 PCR-Based Enzyme Synthesis
6.5 Global Gene Synthesis Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Gene Synthesis Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Gene Synthesis Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Gene Synthesis Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Gene Synthesis Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Gene Synthesis Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Supplier Assessment Framework
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Companies Profiled
18.2.1 ATDBio Ltd
18.2.2 General Biosystems
18.2.3 Macrogen Co., Ltd.
18.2.4 Boster Biological Technology
18.2.5 Creative Biogene
18.2.6 Bioneer Corporation
18.2.7 Exonbio
18.2.8 trenzyme GmbH
18.2.9 Twist Bioscience Corporation
18.2.10 BioCat GmbH
18.2.11 OriGene Technologies, Inc.
18.2.12 Integrated DNA Technologies, Inc.
18.2.13 Eurofins Scientific
18.2.14 NZYTech
18.2.15 Genes and Enzymes
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
For more information about this report visit https://www.researchandmarkets.com/r/dl24kf
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.